Signant Health

Clinical trial technology company providing eCOA, eConsent, IRT, and clinical supplies solutions via its SmartSignals suite.

Signant Health, headquartered in Blue Bell, Pennsylvania, was formed in 2019 from the merger of CRF Health and Bracket under Genstar Capital, combining more than two decades of electronic clinical outcome assessment experience. Its SmartSignals suite spans eCOA, eConsent, telemedicine, IRT/RTSM, clinical supplies management, and endpoint quality analytics, delivered as regulated (GxP) trial systems with 21 CFR Part 11 compliance support.

Headquarters
Blue Bell, United States
Founded
2019
Compliance
21 CFR Part 11, GxP
Deployment options
cloud
Website
https://www.signanthealth.com
LinkedIn
https://www.linkedin.com/company/signant-health

Categories

AI Use Cases

  • Clinical Data Management
  • Digital/Decentralized Trials

Vendor Scorecard

64% — Partial coverage. Coverage score — how completely Atlas documents Signant Health across 7 buyer-evaluation areas. Reflects available Atlas data, not solution quality.

Compliance & Validation — Documented

GxP validated, 21 CFR Part 11

Deployment & Hosting — Documented

cloud

Pricing Transparency — Not documented by Atlas

Ask the vendor: What is your pricing model, and what drives total cost of ownership?

Implementation & Onboarding — Not documented by Atlas

Ask the vendor: What is a realistic implementation timeline, and what onboarding support is included?

Organization & Role Fit — Documented

Mid-Size Biotech, Large Pharma, Top 20 Pharma, CRO / CDMO, Clinical Operations, Data Management

Solution Scope — Documented

Clinical Data Management

Company Viability — Partially documented

Private equity, Founded 2019

Always ask the vendor

Not captured in Atlas data — confirm directly. Excluded from the score above.

Data Rights & IP

Who owns model outputs? Is our proprietary data used to train models others can access, and where does our data reside?

Model Credibility & Explainability

Can you share validation studies or benchmarks, explain how the model reaches its conclusions, and describe how bias and drift are monitored?

Questions to Ask This Vendor

  • Which SmartSignals modules does our study need, and how are they integrated?
  • How is instrument licensing and translation handled for our endpoints?
  • What validation and Part 11 documentation is provided per study?
  • How does endpoint quality monitoring work across sites and modalities?